Bora Pharmaceuticals' Subsidiary Morning Sun Biotech Acquires Health Brand WGN, Marking Another Global Expansion
NQ Score
0/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Bora Pharmaceuticals' subsidiary, Morning Sun Biotech, has acquired the US-based sports nutrition brand Weider Global Nutrition (WGN) for 50 million USD. This acquisition aims to strengthen Bora Pharmaceuticals' global sales strategy and establish it as a leading health food brand group in Taiwan.